PTSD

Face-to-face meetings between victim and perpetrator bring relief to both parties

Psychedelic drugs are poised to be the next major breakthrough in mental health care

Discrimination and stigma are concerns, but coming out can be a boon to your career—if the conditions are right

New clues to fibromyalgia's origins could crack the case of chronic pain

The new identification of possible genetic markers for post-traumatic stress disorder supports treatment with a steroid hormone a few hours after trauma

A good friend of mine passed away in June. John had cancer. Before you offer condolences, you should know he did not want to be mourned. It’s been a hard request to follow, but he felt he had lived a full life.

Implants to restore brain function lost to injury and disease win support from a defense agency

The human brain sprouts more than 1,000 new neurons daily. These cells may hold a secret to treating a range of anxiety disorders

The adult brain generates neurons every day. These cells help us to distinguish one memory from another—a finding that could lead to novel treatments for anxiety disorders

Alexander Shulgin, the most prolific psychedelic chemist in history, has died at the age of 88. I interviewed Shulgin and his wife and co-researcher Ann at their home in California in 1999, when I was researching my 2003 book Rational Mysticism.

New advances in changing memories show the field could hold great promise for both therapy and theory of memory

Everyone has experiences happen to them that they'd rather forget about. Every so often though, you might have a reminder of that experience: perhaps someone says something to you or you see something that jogs your memory.